ILMN
NASDAQ
$192.53
Illumina Inc (ILMN)
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $167.63 (-12.93%)
Market Cap
$29B
Forward P/E
35.59
P/E Ratio
44.12
Free Cash Flow Yield
3.40%
Price Chart
Valuation
Market Cap$29B
P/E44.12
Forward P/E35.59
PEG3.34
P/S6.45
P/B10.81
Profitability
Total Revenue (TTM)$3.23B
Gross Profit (TTM)$3B
EBITDA$1.17B
Profit Margin12.3%
Operating Margin19.2%
EPS$4.24
Financial Health
Free Cash Flow Yield3.40%
Growth & Risk
EPS 5Y CAGR-6.80%
Revenue 5Y CAGR+5.12%
FCF 5Y CAGR+1.82%
Beta (5Y)1.00
Sharpe Ratio1.48